Upgrades
ForDiaMedica Therapeutics Inc(NASDAQ:DMAC), Oppenheimer upgraded the previous rating of Perform to Outperform. In the first quarter, DiaMedica Therapeutics showed an EPS of $0.20, compared to $0.13 from the year-ago quarter. At the moment, the stock has a 52-week-high of $4.05 and a 52-week-low of $1.12. DiaMedica Therapeutics closed at $3.64 at the end of the last trading period.
ForKellogg Co (NYSE:K), Bernstein upgraded the previous rating of Underperform to Market Perform. For the first quarter, Kellogg had an EPS of $1.10, compared to year-ago quarter EPS of $1.10. At the moment, the stock has a 52-week-high...
Login or create a forever free account to read this news
Sign up/Log in